Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-124487
Filing Date
2026-03-25
Accepted
2026-03-25 18:09:57
Documents
1
Period of Report
2026-03-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4086
  Complete submission text file 0001193125-26-124487.txt   5739
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 (781) 281-9020
Damora Therapeutics, Inc. (Issuer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 75 STATE STREET, SUITE 100 C/O GALECTO, INC. BOSTON MA 02109
Business Address
Winslow Garrett (Reporting) CIK: 0001803773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39655 | Film No.: 26793803